Midluteal gonadotropin-releasing hormone analog administration in early pregnancy.
The incidence of GnRH-analog administration in the presence of undiagnosed pregnancy is discussed. Immediate hormonal supplementation avoids luteolysis. The report includes two cases, one without hormonal replacement, in which preclinical pregnancy occurred, and the second, where P was supplemented immediately upon diagnosis of pregnancy.
Ron-El
R
R
Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Tel Aviv University, Israel.
Golan
A
A
Herman
A
A
Raziel
A
A
Soffer
Y
Y
Caspi
E
E
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D002214:Capsules; D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D008183:Luteal Phase / Q000187:drug effects / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D008186:Luteolytic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D008596:Menotropins / Q000008:administration & dosage / Q000494:pharmacology; D010053:Ovary / Q000187:drug effects; D010906:Pituitary Hormone-Releasing Hormones / Q000502:physiology*; D011247:Pregnancy; D011261:Pregnancy Trimester, First / Q000187:drug effects*; D017329:Triptorelin Pamoate
D002214:Capsules; D006063:Chorionic Gonadotropin; D008186:Luteolytic Agents; D010906:Pituitary Hormone-Releasing Hormones; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins; D007986:Luteinizing Hormone